Showing results (421-430 of 479) with videos related to

Sort By:
Pageof 48
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 27, 2004
HMMC-1: a humanized monoclonal antibody with therapeutic potential against Müllerian duct-related carcinomasShiro Nozawa, Daisuke Aoki, Katsumi Tsukazaki, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|October 30, 2015
Pregnancy Outcomes After Abdominal Radical Trachelectomy for Early-Stage Cervical Cancer: A 13-Year Experience in a Single Tertiary-Care CenterYoshifumi Kasuga, Hiroshi Nishio, Kei Miyakoshi, et al.
British Journal of Cancer|July 21, 2017
Whole-genome sequencing revealed novel prognostic biomarkers and promising targets for therapy of ovarian clear cell carcinomaHiroaki Itamochi, Tetsuro Oishi, Nao Oumi, et al.
Genes|October 19, 2016
Methylation Analysis of DNA Mismatch Repair Genes Using DNA Derived from the Peripheral Blood of Patients with Endometrial Cancer: Epimutation in Endometrial CarcinogenesisTakashi Takeda, Kouji Banno, Megumi Yanokura, et al.
Cancer Science|February 4, 2020
Pembrolizumab monotherapy in Japanese patients with advanced ovarian cancer: Subgroup analysis from the KEYNOTE-100Shin Nishio, Koji Matsumoto, Kazuhiro Takehara, et al.
JAMA Oncology|March 22, 2019
Effect of Taxane Plus Platinum Regimens vs Doxorubicin Plus Cisplatin as Adjuvant Chemotherapy for Endometrial Cancer at a High Risk of Progression: A Randomized Clinical TrialHiroyuki Nomura, Daisuke Aoki, Hirofumi Michimae, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 16, 2007
Trophoblast cell activation by trophinin ligation is implicated in human embryo implantationKazuhiro Sugihara, Daijiro Sugiyama, James Byrne, et al.
Anticancer Research|April 1, 2009
Favourable prognosis with modified dosing of docetaxel and cisplatin in Japanese patients with ovarian cancerDaisuke Aoki, Yoh Watanabe, Toshiko Jobo, et al.
Japanese Journal of Clinical Oncology|October 18, 2008
Phase II clinical trial of pegylated liposomal doxorubicin (JNS002) in Japanese patients with mullerian carcinoma (epithelial ovarian carcinoma, primary carcinoma of fallopian tube, peritoneal carcinoma) having a therapeutic history of platinum-based chemotherapy: a Phase II Study of the Japanese Gynecologic Oncology GroupNoriyuki Katsumata, Yasuhiro Fujiwara, Toshiharu Kamura, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|October 25, 2014
Gynecologic Cancer InterGroup (GCIG) consensus review for uterine serous carcinomaSatoru Sagae, Nobuyuki Susumu, Akila N Viswanathan, et al.
Pageof 48